Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of HDAC-Mediated Repression and Gain of NF-κB Activation Underlie Cytokine Induction in ARID1A- and PIK3CA-Mutation-Driven Ovarian Cancer

1 Sept 2016

Abstract excerpt

ARID1A is frequently mutated in ovarian clear cell carcinoma (OCCC) and often co-exists with activating mutations of PIK3CA. Although induction of pro-inflammatory cytokines has been observed in this cancer, the mechanism by which the two mutations synergistically activate cytokine genes remains elusive. Here, we established an in vitro model of OCCC by introducing ARID1A knockdown and mutant PIK3CA into a normal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Chromatin Remodeling and Cancer
Share to Histone Deacetylase Inhibitors Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27681437
DOI: 10.1016/j.celrep.2016.09.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of HDAC-Mediated Repression and Gain of NF-κB Activation Underlie Cytokine Induction in ARID1A- and PIK3CA-Mutation-Driven Ovarian CancerPMID 27681437Read ↗

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.Semantic proximity Read ↗

Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis.Semantic proximity Read ↗

Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer.Semantic proximity Read ↗

HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian CancerSemantic proximity Read ↗

Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.Semantic proximity Read ↗

Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinomaSemantic proximity Read ↗

Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A-Mutant Ovarian Cancers.Semantic proximity Read ↗

Loss of LKB1-NUAK1 Signalling Enhances NF-κB Activity in a Spheroid Model of High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Vorinostat decrease M2 macrophage polarization through ARID1A6488delG/HDAC6/IL-10 signaling pathway in endometriosis-associated ovarian carcinomaSemantic proximity Read ↗

Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity.Semantic proximity Read ↗

AP-1 Subunit JUNB Promotes Invasive Phenotypes in Endometriosis.Semantic proximity Read ↗

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.